Previously studied for its potential to treat cancer, NSC95397 is a Cdc25 phosphatase inhibitor that can also inhibit many members of the dual-specificity phosphatase (DUSP) family, specifically DUSP1 (MKP1), DUSP6 (MKP3), and DSUP14 (MKP6) [10,11,12,13], which are key to cell proliferation and response to infection. Here, DUSP6 is linked to infection.